FEDERAL HEALTH POLICY STRATEGIES for UPMC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
| THOMAS SCULLY | — |
Health Issues HCR
Issues related to CMS inpatient hospital prospective payment system proposed rule development; issues related to House Energy and Commerce Committee hearings on heath care transparency; isssues related to CMS Advance Notice of Methodological Changes and Parts C & D Capitation Rates for 2024; issues related to CMS proposed rule relating to policy and technical changes to Medicare Advantage and Prescription Drug Programs; issues related to pending expiration of COVID-19 Public Health Emergency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COLIN ROSKEY | — |
| THOMAS SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.